Lactic Acid

CHEMBL1200559 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
90.1 g/mol
LogP
-0.7
Phase
4

This naturally occurring organic acid is used in various medical applications including as a component of balanced intravenous fluids, topical treatments for skin conditions like keratosis, and vaginal pH-restoring preparations. At low concentrations in creams, it acts as an exfoliant and moisturizer by helping skin retain water.

Masse moléculaire

90,0800 g/mol

LogP

-0,70

TPSA

57,50 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Mécanisme d'action

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mécanisme

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(O)C(=O)O

InChI

InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)

Molecular Formula

C3H6O3

HBD / HBA

2 / 3

Liaisons Rotatives

1

Atomes Lourds

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This naturally occurring organic acid is used in various medical applications including as a component of balanced intravenous fluids, topical treatments for skin conditions like keratosis, and vaginal pH-restoring preparations. At low concentrations in creams, it acts as an exfoliant and moisturizer by helping skin retain water.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Lactic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200559. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 612. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.